InsiderClue
Stocks · Health care · Pharmaceutical Preparations

IMMUTEP Ltd

IMMP Clue Score48
Australia Fiscal year ends June CIK 0001506184
$3.57 -2.72% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.57 −8.70% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 14 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2017Revenue4.2Net income−9.4EPS, diluted−0.40Fiscal year 2018Revenue7.4 +74.2%Net income−12.7EPS, diluted−4.63Fiscal year 2019Revenue7.5 +1.9%Net income−18.3EPS, diluted−5.29Fiscal year 2020Revenue16.5 +120.3%Net income−13.5EPS, diluted−0.03Fiscal year 2021Revenue4.0 −76.0%Net income−29.9EPS, diluted−0.05Fiscal year 2022Revenue6.8 +70.3%Net income−32.2EPS, diluted−0.04Fiscal year 2023Revenue5.2 −23.1%Net income−39.9EPS, diluted−0.04Fiscal year 2024Revenue7.8 +50.7%Net income−42.7EPS, diluted−0.04Fiscal year 2025Revenue10.3 +31.8%Net income−61.4EPS, diluted−0.04
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.2 7.4 7.5 16.5 4.0 6.8 5.2 7.8 10.3
Growth +74.2% +1.9% +120.3% −76.0% +70.3% −23.1% +50.7% +31.8%
Net income −9.4 −12.7 −18.3 −13.5 −29.9 −32.2 −39.9 −42.7 −61.4
Growth
EPS, diluted −0.40 −4.63 −5.29 −0.03 −0.05 −0.04 −0.04 −0.04 −0.04

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2017Net margin−221.9%Free cash flow margin−201.7%Fiscal year 2018Net margin−173.3%Free cash flow margin−105.9%Fiscal year 2019Net margin−244.9%Free cash flow margin−204.7%Fiscal year 2020Net margin−81.6%Free cash flow margin−65.8%Fiscal year 2021Net margin−753.6%Free cash flow margin−444.9%Fiscal year 2022Net margin−476.6%Free cash flow margin−447.7%Fiscal year 2023Net margin−767.2%Free cash flow margin−681.5%Fiscal year 2024Net margin−545.0%Free cash flow margin−444.6%Fiscal year 2025Net margin−594.6%Free cash flow margin−601.0%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin −221.9% −173.3% −244.9% −81.6% −753.6% −476.6% −767.2% −545.0% −594.6%
Free cash flow margin −201.7% −105.9% −204.7% −65.8% −444.9% −447.7% −681.5% −444.6% −601.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−8.5Capital expenditure−0.0Free cash flow−8.5Fiscal year 2018Operating cash flow−7.8Capital expenditure−0.0Free cash flow−7.8Fiscal year 2019Operating cash flow−15.3Capital expenditure−0.0Free cash flow−15.3Fiscal year 2020Operating cash flow−10.8Capital expenditure−0.0Free cash flow−10.9Fiscal year 2021Operating cash flow−17.6Capital expenditure−0.0Free cash flow−17.7Fiscal year 2022Operating cash flow−30.2Capital expenditure−0.0Free cash flow−30.3Fiscal year 2023Operating cash flow−35.4Capital expenditure−0.1Free cash flow−35.4Fiscal year 2024Operating cash flow−34.8Capital expenditure−0.0Free cash flow−34.9Fiscal year 2025Operating cash flow−62.0Capital expenditure−0.0Free cash flow−62.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.5 −7.8 −15.3 −10.8 −17.6 −30.2 −35.4 −34.8 −62.0
Capital expenditure −0.0 −0.0 −0.0 −0.0 −0.0 −0.0 −0.1 −0.0 −0.0
Free cash flow −8.5 −7.8 −15.3 −10.9 −17.7 −30.3 −35.4 −34.9 −62.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2017Cash and securities12.2Shareholders’ equity26.5Fiscal year 2018Cash and securities23.5Shareholders’ equity33.5Fiscal year 2019Cash and securities16.6Shareholders’ equity24.4Fiscal year 2020Cash and securities26.3Shareholders’ equity33.3Fiscal year 2021Cash and securities60.6Shareholders’ equity73.3Fiscal year 2022Cash and securities80.0Shareholders’ equity94.1Fiscal year 2023Cash and securities123.4Shareholders’ equity136.5Fiscal year 2024Cash and securities161.8Shareholders’ equity189.5Fiscal year 2025Cash and securities67.4Shareholders’ equity143.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 12.2 23.5 16.6 26.3 60.6 80.0 123.4 161.8 67.4
Shareholders’ equity 26.5 33.5 24.4 33.3 73.3 94.1 136.5 189.5 143.6

In millions of AUD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of AUD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018† 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025
Revenue and profit
4.2 7.4 7.5 16.5 4.0 6.8 5.2 7.8 10.3
Growth +74.2% +1.9% +120.3% −76.0% +70.3% −23.1% +50.7% +31.8%
7.5 10.0 13.8 15.6 12.0 25.3 28.8 31.5 49.8
4.3 7.2 6.4 6.3 6.3 7.2 8.7 8.9 8.6
−10.1 −12.7 −18.3 −13.5 −29.9 −32.2 −39.9 −42.7 −61.4
−0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−9.4 −12.7 −18.3 −13.5 −29.9 −32.2 −39.9 −42.7 −61.4
Growth
Per share
−0.40 −4.63 −5.29 −0.03 −0.05 −0.04 −0.04 −0.04 −0.04
−0.40 −4.63 −5.29 −0.03 −0.05 −0.04 −0.04 −0.04 −0.04
Growth
2,370 275.1 346.8 412.9 594.9 849.0 892.4 1,201 1,456
2,370 275.1 346.8 412.9 594.9 849.0 892.4 1,201 1,456
Growth +26.1% +19.0% +44.1% +42.7% +5.1% +34.6% +21.2%

† The diluted share count jumps at 2018, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Shown in AUD as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 8.9% a year over five years.
  • A net loss in 9 of 9 years on file.